NCT03106298View on ClinicalTrials.gov

Iron Deficiency and FGF23 Regulation in CKD and HF

CompletedOBSERVATIONAL
Enrollment

77

Participants

Timeline

Start Date

December 18, 2015

Primary Completion Date

August 1, 2018

Study Completion Date

August 1, 2018

Conditions
Chronic Kidney DiseasesChronic Heart FailureIron Deficiency Anemia
Interventions
DRUG

Iron Sucrose

All participants will be given intravenous iron sucrose (200 mg) weekly for 5 weeks. Iron sucrose is infused over 60 minutes.

Trial Locations (1)

60607

Northwestern University, Chicago

All Listed Sponsors
collaborator

National Kidney Foundation, United States

OTHER

lead

Northwestern University

OTHER

NCT03106298 - Iron Deficiency and FGF23 Regulation in CKD and HF | Biotech Hunter | Biotech Hunter